{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:07:38Z","timestamp":1791925658975,"version":"4.3.4"},"reference-count":326,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is the most common neurodegenerative disorder with the majority of patients classified as sporadic AD (sAD), in which etiopathogenesis remains unresolved. Though sAD is argued to be a polygenic disorder, apolipoprotein E (APOE) \u03b54, was found three decades ago to pose the strongest genetic risk for sAD. Currently, the only clinically approved disease-modifying drugs for AD are aducanumab (Aduhelm) and lecanemab (Leqembi). All other AD treatment options are purely symptomatic with modest benefits. Similarly, attention-deficit hyperactivity disorder (ADHD), is one of the most common neurodevelopmental mental disorders in children and adolescents, acknowledged to persist in adulthood in over 60% of the patients. Moreover, for ADHD whose etiopathogenesis is not completely understood, a large proportion of patients respond well to treatment (first-line psychostimulants, e.g., methylphenidate\/MPH), however, no disease-modifying therapy exists. Interestingly, cognitive impairments, executive, and memory deficits seem to be common in ADHD, but also in early stages of mild cognitive impairment (MCI), and dementia, including sAD. Therefore, one of many hypotheses is that ADHD and sAD might have similar origins or that they intercalate with one another, as shown recently that ADHD may be considered a risk factor for sAD. Intriguingly, several overlaps have been shown between the two disorders, e.g., inflammatory activation, oxidative stress, glucose and insulin pathways, wingless-INT\/mammalian target of rapamycin (Wnt\/mTOR) signaling, and altered lipid metabolism. Indeed, Wnt\/mTOR activities were found to be modified by MPH in several ADHD studies. Wnt\/mTOR was also found to play a role in sAD and in animal models of the disorder. Moreover, MPH treatment in the MCI phase was shown to be successful for apathy including some improvement in cognition, according to a recent meta-analysis. In several AD animal models, ADHD-like behavioral phenotypes have been observed indicating a possible interconnection between ADHD and AD. In this concept paper, we will discuss the various evidence in human and animal models supporting the hypothesis in which ADHD might increase the risk for sAD, with common involvement of the Wnt\/mTOR-pathway leading to lifespan alteration at the neuronal levels.<\/jats:p>","DOI":"10.3389\/fnins.2023.1104985","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T06:26:28Z","timestamp":1676528788000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["From attention-deficit hyperactivity disorder to sporadic Alzheimer\u2019s disease\u2014Wnt\/mTOR pathways hypothesis"],"prefix":"10.3389","volume":"17","author":[{"given":"Edna","family":"Gr\u00fcnblatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Homolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Babic Perhoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virag","family":"Davor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Knezovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Osmanovic Barilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Riederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Walitza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Tackenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melita","family":"Salkovic-Petrisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"113799","DOI":"10.1016\/j.biopha.2022.113799","article-title":"The protective effect of thymoquinone or\/and thymol against monosodium glutamate-induced attention-deficit\/hyperactivity disorder (ADHD)-like behavior in rats: Modulation of Nrf2\/HO-1, TLR4\/NF-kappaB\/NLRP3\/caspase-1 and Wnt\/beta-Catenin signaling pathways in rat model.","volume":"155","author":"Abu-Elfotuh","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1479164117738442","article-title":"Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases.","volume":"15","author":"Ackers","year":"2018","journal-title":"Diab Vasc Dis Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1089\/ars.2016.6860","article-title":"Reactive oxygen species-mediated loss of synaptic Akt1 signaling leads to deficient activity-dependent protein translation early in Alzheimer\u2019s disease.","volume":"27","author":"Ahmad","year":"2017","journal-title":"Antioxid. Redox. Signal."},{"key":"B4","doi-asserted-by":"publisher","first-page":"936813","DOI":"10.3389\/fped.2022.936813","article-title":"The relationship between diabetes mellitus and attention deficit hyperactivity disorder: A systematic review and meta-analysis.","volume":"10","author":"Ai","year":"2022","journal-title":"Front. Pediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12935-022-02706-8","article-title":"Recent advances and limitations of mTOR inhibitors in the treatment of cancer.","volume":"22","author":"Ali","year":"2022","journal-title":"Cancer Cell Int."},{"key":"B6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.5483\/BMBRep.2017.50.12.206","article-title":"Upstream signalling of mTORC1 and its hyperactivation in type 2 diabetes (T2D).","volume":"50","author":"Ali","year":"2017","journal-title":"BMB Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/JAD-210234","article-title":"Insulin resistance as a common link between current Alzheimer\u2019s disease hypotheses.","volume":"82","author":"Alves","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"B8","year":"2022","journal-title":"Dementia statistics [Online]. Alzheimer\u2019s disease international."},{"key":"B9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41398-019-0388-7","article-title":"S-nitrosylation of E3 ubiquitin-protein ligase RNF213 alters non-canonical Wnt\/Ca+2 signaling in the P301S mouse model of tauopathy.","volume":"9","author":"Amal","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"B10","year":"2013","journal-title":"Diagnostic and statistical manual of mental disorders: DSM-5."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.3390\/ijms20143537","article-title":"Genetic associations between voltage-gated calcium channels and psychiatric disorders.","volume":"20","author":"Andrade","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e73138","DOI":"10.7554\/eLife.73138","article-title":"Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses.","volume":"11","author":"Antal","year":"2022","journal-title":"Elife"},{"key":"B13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0006-8993(00)03186-3","article-title":"Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes.","volume":"891","author":"Arendash","year":"2001","journal-title":"Brain Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2174\/1567205014666170505095921","article-title":"Reduced mitochondrial activity is early and steady in the entorhinal cortex but it is mainly unmodified in the frontal cortex in Alzheimer\u2019s disease.","volume":"14","author":"Armand-Ugon","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.apsb.2021.06.014","article-title":"Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer\u2019s disease.","volume":"12","author":"Austad","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1074\/jbc.M112.409250","article-title":"Inhibition of glycogen synthase kinase-3 ameliorates beta-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: In vivo and in vitro studies.","volume":"288","author":"Avrahami","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neuropharm.2018.12.018","article-title":"Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice.","volume":"148","author":"Babic Perhoc","year":"2019","journal-title":"Neuropharmacology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fncel.2018.00488","article-title":"Microglia in neurological diseases: A road map to brain-disease dependent-inflammatory response.","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"B19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1364-6613(00)01538-2","article-title":"The episodic buffer: A new component of working memory?","volume":"4","author":"Baddeley","year":"2000","journal-title":"Trends Cogn. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10827-012-0391-y","article-title":"Computational model of excitatory\/inhibitory ratio imbalance role in attention deficit disorders.","volume":"33","author":"Bakhtiari","year":"2012","journal-title":"J. Comput. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1080\/13102818.2021.1964382","article-title":"Rare genetic variants prioritize molecular pathways for semaphorin interactions in Alzheimer\u2019s disease patients.","volume":"35","author":"Balabanski","year":"2021","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"B22","author":"Banaschewski","year":"2018","journal-title":"Aufmerksamkeitsdefizit-\/hyperaktivit\u00e4tsst\u00f6rung (ADHS) im kindes- jugend- und erwachsenenalter."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/fcp.12677","article-title":"Everolimus: A potential therapeutic agent targeting PI3K\/Akt pathway in brain insulin system dysfunction and associated neurobehavioral deficits.","volume":"35","author":"Bansal","year":"2021","journal-title":"Fundam. Clin. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.nlm.2010.10.008","article-title":"Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer\u2019s disease.","volume":"95","author":"Bardgett","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00702-014-1323-y","article-title":"Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer\u2019s disease.","volume":"122","author":"Barilar","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12402-010-0039-6","article-title":"Effects of methylphenidate: The cellular point of view.","volume":"2","author":"Bartl","year":"2010","journal-title":"Atten. Defic. Hyperact. Disord."},{"key":"B27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/15622975.2011.650204","article-title":"Alzheimer\u2019s disease and type 2 diabetes: Two diseases, one common link?","volume":"14","author":"Bartl","year":"","journal-title":"World J. Biol. Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2049-9256-1-5","article-title":"Methylphenidate enhances neural stem cell differentiation.","volume":"1","author":"Bartl","year":"","journal-title":"J. Mol. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pnpbp.2017.07.002","article-title":"The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro.","volume":"79","author":"Bartl","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.acn.2005.07.002","article-title":"Executive function deficits in early Alzheimer\u2019s disease and their relations with episodic memory.","volume":"21","author":"Baudic","year":"2006","journal-title":"Arch. Clin. Neuropsychol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"11686","DOI":"10.1073\/pnas.1103098108","article-title":"Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice.","volume":"108","author":"Bedrosian","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnins.2015.00204","article-title":"Aberrant insulin signaling in Alzheimer\u2019s disease: Current knowledge.","volume":"9","author":"Bedse","year":"2015","journal-title":"Front. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias.","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1007\/s00018-015-2028-6","article-title":"Canonical and noncanonical Wnt signaling in neural stem\/progenitor cells.","volume":"72","author":"Bengoa-Vergniory","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.4161\/cc.5.18.3288","article-title":"Aging and immortality: Quasi-programmed senescence and its pharmacologic inhibition.","volume":"5","author":"Blagosklonny","year":"2006","journal-title":"Cell Cycle"},{"key":"B36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.neuropharm.2017.09.016","article-title":"Reduced brain insulin signaling: A seminal process in Alzheimer\u2019s disease pathogenesis.","volume":"136","author":"Bloom","year":"2018","journal-title":"Neuropharmacology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/alz.12181","article-title":"Non-coding variants in MYH11, FZD3, and SORCS3 are associated with dementia in women.","volume":"17","author":"Blue","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.arr.2008.11.003","article-title":"Wnt signaling in Alzheimer\u2019s disease: Up or down, that is the question.","volume":"8","author":"Boonen","year":"2009","journal-title":"Ageing Res. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41398-022-02182-8","article-title":"Comprehensive analysis of omics data identifies relevant gene networks for Attention-Deficit\/Hyperactivity Disorder (ADHD).","volume":"12","author":"Cabana-Dominguez","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2147\/NDT.S75717","article-title":"Activation of mTOR: A culprit of Alzheimer\u2019s disease?","volume":"11","author":"Cai","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B41","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fnagi.2017.00260","article-title":"Adult ADHD: Risk factor for dementia or phenotypic mimic?","volume":"9","author":"Callahan","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/10870547211060546","article-title":"Cognitive and neuroimaging profiles of older adults with attention deficit\/hyperactivity disorder presenting to a memory clinic.","volume":"26","author":"Callahan","year":"2022","journal-title":"J. Atten. Disord."},{"key":"B43","doi-asserted-by":"publisher","first-page":"726374","DOI":"10.3389\/fnagi.2021.726374","article-title":"Longitudinal cognitive performance of older adults with ADHD presenting to a cognitive neurology clinic: A case series of change up to 21 years.","volume":"13","author":"Callahan","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.neubiorev.2021.11.012","article-title":"ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications.","volume":"132","author":"Cannon Homaei","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1523\/JNEUROSCI.1381-04.2004","article-title":"Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer\u2019s brain.","volume":"24","author":"Caricasole","year":"2004","journal-title":"J. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1471-4159.2006.03867.x","article-title":"Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells.","volume":"98","author":"Caruso","year":"2006","journal-title":"J. Neurochem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrn896","article-title":"Neuroscience of attention-deficit\/hyperactivity disorder: The search for endophenotypes.","volume":"3","author":"Castellanos","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/11539440-000000000-00000","article-title":"Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: A meta-regression analysis.","volume":"25","author":"Castells","year":"2011","journal-title":"CNS Drugs"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/S2215-0366(19)30482-1","article-title":"Disparate regulatory status of methylphenidate for adults with ADHD across Europe.","volume":"7","author":"Chappuy","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0204516","DOI":"10.1371\/journal.pone.0204516","article-title":"Common psychiatric and metabolic comorbidity of adult attention-deficit\/hyperactivity disorder: A population-based cross-sectional study.","volume":"13","author":"Chen","year":"2018","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s12035-012-8375-5","article-title":"A non-transgenic mouse model (icv-STZ mouse) of Alzheimer\u2019s disease: Similarities to and differences from the transgenic model (3xTg-AD mouse).","volume":"47","author":"Chen","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e51432","DOI":"10.1371\/journal.pone.0051432","article-title":"Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer\u2019s disease.","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.2337\/db14-1439","article-title":"Wnt signaling regulates blood pressure by downregulating a GSK-3beta-mediated pathway to enhance insulin signaling in the central nervous system.","volume":"64","author":"Cheng","year":"2015","journal-title":"Diabetes"},{"key":"B54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.autneu.2018.12.002","article-title":"Microglia in the RVLM of SHR have reduced P2Y12R and CX3CR1 expression, shorter processes, and lower cell density.","volume":"216","author":"Cohen","year":"2019","journal-title":"Auton. Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e0130177","DOI":"10.1371\/journal.pone.0130177","article-title":"Sleep-wake cycle dysfunction in the TgCRND8 mouse model of Alzheimer\u2019s disease: From early to advanced pathological stages.","volume":"10","author":"Colby-Milley","year":"2015","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00702-021-02422-z","article-title":"Abstracts of the WASAD Congress, 2021: An international congress of the world association for stress related and anxiety disorders, held on 20-22 September 2021 in Vienna, Austria.","volume":"128","author":"Congress","year":"2021","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/antiox9111039","article-title":"Role of oxidative stress and neuroinflammation in attention-deficit\/hyperactivity disorder.","volume":"9","author":"Corona","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.arr.2011.01.001","article-title":"Insulin-resistant brain state: The culprit in sporadic Alzheimer\u2019s disease?","volume":"10","author":"Correia","year":"2011","journal-title":"Ageing Res. Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis.","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e421","DOI":"10.4088\/JCP.14m09630","article-title":"Gender differences in adult attention-deficit\/hyperactivity disorder: Results from the national epidemiologic survey on alcohol and related conditions (NESARC).","volume":"77","author":"Cortese","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuroscience.2018.08.008","article-title":"Overexpression of the thyroid hormone-responsive (THRSP) Gene in the striatum leads to the development of inattentive-like phenotype in mice.","volume":"390","author":"Custodio","year":"2018","journal-title":"Neuroscience"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s42003-022-04387-5","article-title":"Hippocampal dentate gyri proteomics reveals Wnt signaling involvement in the behavioral impairment in the THRSP-overexpressing ADHD mouse model","author":"Custodio","year":"2023","journal-title":"Commun. Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1474-9726.2010.00660.x","article-title":"Age-related alterations in the dynamic behavior of microglia.","volume":"10","author":"Damani","year":"2011","journal-title":"Aging Cell"},{"key":"B64","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.jalz.2013.12.004","article-title":"How does brain insulin resistance develop in Alzheimer\u2019s disease?","volume":"10","author":"De Felice","year":"2014","journal-title":"Alzheimers Dement."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1101\/19012021","article-title":"Common variants in Alzheimer\u2019s disease: Novel association of six genetic variants with AD and risk stratification by polygenic risk scores.","author":"de Rojas","year":"2020","journal-title":"medRxiv"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","article-title":"Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores.","volume":"12","author":"de Rojas","year":"2021","journal-title":"Nat. Commun."},{"key":"B67","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-013-3168-8","article-title":"Neuronal development genes are key elements mediating the reinforcing effects of methamphetamine, amphetamine, and methylphenidate.","volume":"230","author":"Dela Pena","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1038\/s41380-020-00997-9","article-title":"Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders.","volume":"26","author":"Delhaye","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1744-9081-2-10","article-title":"Relationship between impulsivity, hyperactivity and working memory: A differential analysis in the rat.","volume":"2","author":"Dellu-Hagedorn","year":"2006","journal-title":"Behav. Brain Funct."},{"key":"B70","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.neurobiolaging.2003.06.006","article-title":"Impulsivity in youth predicts early age-related cognitive deficits in rats.","volume":"25","author":"Dellu-Hagedorn","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01285-8","article-title":"Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains","author":"Demontis","year":"2023","journal-title":"Nat. Genet."},{"key":"B72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41588-018-0269-7","article-title":"Discovery of the first genome-wide significant risk loci for attention deficit\/hyperactivity disorder.","volume":"51","author":"Demontis","year":"2019","journal-title":"Nat. Genet."},{"key":"B73","doi-asserted-by":"publisher","first-page":"891479","DOI":"10.3389\/fpsyt.2022.891479","article-title":"Prevalence of metabolic syndrome and insulin resistance in a sample of adult ADHD outpatients.","volume":"13","author":"di Girolamo","year":"2022","journal-title":"Front. Psychiatry"},{"key":"B74","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1017\/neu.2021.23","article-title":"Children and adolescents with ADHD followed up to adulthood: A systematic review of long-term outcomes.","volume":"33","author":"Di Lorenzo","year":"2021","journal-title":"Acta Neuropsychiatr."},{"key":"B75","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-psych-113011-143750","article-title":"Executive functions.","volume":"64","author":"Diamond","year":"2013","journal-title":"Annu. Rev. Psychol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/j.eurpsy.2021.2261","article-title":"Attention-deficit\/hyperactivity disorder as a risk factor for dementia and mild cognitive impairment: A population-based register study.","volume":"65","author":"Dobrosavljevic","year":"2021","journal-title":"Eur. Psychiatry"},{"key":"B77","doi-asserted-by":"publisher","first-page":"7550","DOI":"10.3390\/ijms23147550","article-title":"Modelling autism spectrum disorder (ASD) and attention-deficit\/hyperactivity disorder (ADHD) using mice and zebrafish.","volume":"23","author":"Dougnon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.bbapap.2009.12.001","article-title":"Dissecting the role of mTOR: Lessons from mTOR inhibitors.","volume":"1804","author":"Dowling","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"B79","doi-asserted-by":"publisher","first-page":"733012","DOI":"10.3389\/fnmol.2021.733012","article-title":"Neurodevelopmental disorders (n.d.) caused by genomic alterations of the ubiquitin-proteasome system (UPS): The possible contribution of immune dysregulation to disease pathogenesis.","volume":"14","author":"Ebstein","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"666502","DOI":"10.3389\/fphar.2021.666502","article-title":"Enhancement of insulin\/PI3K\/Akt signaling pathway and modulation of gut microbiome by probiotics fermentation technology, a kefir grain product, in sporadic Alzheimer\u2019s disease model in mice.","volume":"12","author":"El Sayed","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41398-022-01817-0","article-title":"Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders.","volume":"12","author":"Fanelli","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00787-009-0054-3","article-title":"Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis.","volume":"19","author":"Faraone","year":"2010","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"B83","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41380-018-0070-0","article-title":"Genetics of attention deficit hyperactivity disorder.","volume":"24","author":"Faraone","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"B84","doi-asserted-by":"publisher","first-page":"15020","DOI":"10.1038\/nrdp.2015.20","article-title":"Attention-deficit\/hyperactivity disorder.","volume":"1","author":"Faraone","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B85","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12402-016-0208-3","article-title":"The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys.","volume":"9","author":"Fayyad","year":"2017","journal-title":"Atten. Defic. Hyperact. Disord."},{"key":"B86","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000364932","article-title":"Development and aging: Two opposite but complementary phenomena.","volume":"40","author":"Feltes","year":"2015","journal-title":"Interdiscip. Top. Gerontol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s40473-019-00179-0","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease and progress in mitochondria-targeted therapeutics.","volume":"6","author":"Flannery","year":"2019","journal-title":"Curr. Behav. Neurosci. Rep."},{"key":"B88","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12974-017-0840-7","article-title":"Proteomic anaysis of aged microglia: Shifts in transcription, bioenergetics, and nutrient response.","volume":"14","author":"Flowers","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"B89","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuint.2017.08.005","article-title":"Antecedent ADHD, dementia, and metabolic dysregulation: A U.S. based cohort analysis.","volume":"112","author":"Fluegge","year":"2018","journal-title":"Neurochem. Int."},{"key":"B90","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s12035-018-1103-z","article-title":"Impaired Wnt signaling in the prefrontal cortex of Alzheimer\u2019s disease.","volume":"56","author":"Folke","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neuropharm.2012.08.015","article-title":"The involvement of reelin in neurodevelopmental disorders.","volume":"68","author":"Folsom","year":"2013","journal-title":"Neuropharmacology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"110518","DOI":"10.1016\/j.pnpbp.2022.110518","article-title":"Evidence of methylphenidate effect on mitochondria, redox homeostasis, and inflammatory aspects: Insights from animal studies.","volume":"116","author":"Foschiera","year":"2022","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B93","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0166-4328(01)00379-5","article-title":"Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup.","volume":"131","author":"Fox","year":"2002","journal-title":"Behav. Brain Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12974-014-0139-x","article-title":"Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic mice.","volume":"11","author":"Francois","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"B95","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/mp.2011.138","article-title":"The genetics of attention deficit\/hyperactivity disorder in adults, a review.","volume":"17","author":"Franke","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.euroneuro.2018.08.001","article-title":"Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan.","volume":"28","author":"Franke","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer\u2019s disease.","volume":"105","author":"Fr\u00f6lich","year":"1998","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B98","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41398-022-01919-9","article-title":"The role of ADHD genetic risk in mid-to-late life somatic health conditions.","volume":"12","author":"Garcia-Argibay","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"B99","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/dev.21286","article-title":"Cross-fostering differentially affects ADHD-related behaviors in spontaneously hypertensive rats.","volume":"57","author":"Gauthier","year":"2015","journal-title":"Dev. Psychobiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019.","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e0175433","DOI":"10.1371\/journal.pone.0175433","article-title":"The brain anatomy of attention-deficit\/hyperactivity disorder in young adults \u2013 A magnetic resonance imaging study.","volume":"12","author":"Gehricke","year":"2017","journal-title":"PLoS One"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11065-005-3583-7","article-title":"Working memory and learning in early Alzheimer\u2019s disease.","volume":"15","author":"Germano","year":"2005","journal-title":"Neuropsychol. Rev."},{"key":"B103","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1468-1331.2010.03064.x","article-title":"Previous adult attention-deficit and hyperactivity disorder symptoms and risk of dementia with Lewy bodies: A case-control study.","volume":"18","author":"Golimstok","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.tins.2008.09.010","article-title":"The dopaminergic hypothesis of attention-deficit\/hyperactivity disorder needs re-examining.","volume":"32","author":"Gonon","year":"2009","journal-title":"Trends Neurosci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3109\/07420528.2010.485711","article-title":"Lifespan daily locomotor activity rhythms in a mouse model of amyloid-induced neuropathology.","volume":"27","author":"Gorman","year":"2010","journal-title":"Chronobiol. Int."},{"key":"B106","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/jcm8050651","article-title":"Vascular dysfunction in Alzheimer\u2019s disease: A prelude to the pathological process or a consequence of it?","volume":"8","author":"Govindpani","year":"2019","journal-title":"J. Clin. Med."},{"key":"B107","article-title":"Sex differences in ADHD","author":"Greven","year":"2018","journal-title":"Oxford textbook of attention deficit hyperactivity disorder"},{"key":"B108","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41398-018-0096-8","article-title":"Methylphenidate enhances neuronal differentiation and reduces proliferation concomitant to activation of Wnt signal transduction pathways.","volume":"8","author":"Gr\u00fcnblatt","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"B109","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40303-015-0012-6","article-title":"Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction.","volume":"3","author":"Gr\u00fcnblatt","year":"2015","journal-title":"J. Mol. Psychiatry"},{"key":"B110","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/ajmg.b.32695","article-title":"The involvement of the canonical Wnt-signaling receptor LRP5 and LRP6 gene variants with ADHD and sexual dimorphism: Association study and meta-analysis.","volume":"180","author":"Gr\u00fcnblatt","year":"2019","journal-title":"Am. J. Med. Genet. Part B"},{"key":"B111","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1471-4159.2006.04368.x","article-title":"Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein.","volume":"101","author":"Gr\u00fcnblatt","year":"2007","journal-title":"J. Neurochem."},{"key":"B112","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fendo.2018.00621","article-title":"mTORC1 overactivation as a key aging factor in the progression to Type 2 diabetes mellitus.","volume":"9","author":"Guillen","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B113","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-beta pathway in Alzheimer\u2019s disease.","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B114","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mcn.2008.06.003","article-title":"Mammalian target of rapamycin (mTOR) is involved in the neuronal differentiation of neural progenitors induced by insulin.","volume":"39","author":"Han","year":"2008","journal-title":"Mol. Cell Neurosci."},{"key":"B115","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1038\/s41598-022-07029-2","article-title":"A role for cortical dopamine in the paradoxical calming effects of psychostimulants.","volume":"12","author":"Harris","year":"2022","journal-title":"Sci. Rep."},{"key":"B116","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000516164","article-title":"A systematic review of the association between amyloid-beta and tau pathology with functional connectivity alterations in the Alzheimer dementia spectrum utilizing PET Scan and rsfMRI.","volume":"11","author":"Hasani","year":"2021","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"B117","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pharmthera.2015.11.010","article-title":"Low attentive and high impulsive rats: A translational animal model of ADHD and disorders of attention and impulse control.","volume":"158","author":"Hayward","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B118","doi-asserted-by":"publisher","first-page":"6545","DOI":"10.1523\/jneurosci.0421-09.2009","article-title":"Interruption of \u03b2-catenin signaling reduces neurogenesis in Alzheimer\u2019s disease.","volume":"29","author":"He","year":"2009","journal-title":"J. Neurosci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0031-9384(85)90199-4","article-title":"Age, sex and strain differences in activity and habituation in SHR and WKY Rats.","volume":"34","author":"Hendley","year":"1985","journal-title":"Physiol. Behav."},{"key":"B120","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrendo.2015.173","article-title":"Impaired insulin action in the human brain: Causes and metabolic consequences.","volume":"11","author":"Heni","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.3233\/JAD-2012-129025","article-title":"GSK3 and tau: Two convergence points in Alzheimer\u2019s disease.","volume":"33","author":"Hernandez","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B122","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41386-018-0090-0","article-title":"Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.","volume":"44","author":"Holper","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11011-020-00637-9","article-title":"Additional methodological considerations regarding optimization of the dose of intracerebroventricular streptozotocin A response to: \u201cOptimization of intracerebroventricular streptozotocin dose for the induction of neuroinflammation and memory impairments in rats\u201d by Ghosh et al., Metab Brain Dis 2020 July 21.","volume":"36","author":"Homolak","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S2215-0366(17)30049-4","article-title":"Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: A cross-sectional mega-analysis.","volume":"4","author":"Hoogman","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"B125","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1037\/a0015632","article-title":"Voluntary physical exercise alters attentional orienting and social behavior in a rat model of attention-deficit\/hyperactivity disorder.","volume":"123","author":"Hopkins","year":"2009","journal-title":"Behav. Neurosci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"837424","DOI":"10.3389\/fpsyt.2022.837424","article-title":"ASD and ADHD comorbidity: What are we talking about?","volume":"13","author":"Hours","year":"2022","journal-title":"Front. Psychiatry"},{"key":"B127","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnagi.2018.00164","article-title":"The role of fluoxetine in activating Wnt\/beta-catenin signaling and repressing beta-amyloid production in an Alzheimer mouse model.","volume":"10","author":"Huang","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"105389","DOI":"10.1016\/j.neuint.2022.105389","article-title":"Inhibition of Wnt\/beta-catenin signaling attenuates axonal degeneration in models of Parkinson\u2019s disease.","volume":"159","author":"Huang","year":"2022","journal-title":"Neurochem. Int."},{"key":"B129","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.neubiorev.2014.09.005","article-title":"Wnt signaling in neuropsychiatric disorders: Ties with adult hippocampal neurogenesis and behavior.","volume":"47","author":"Hussaini","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B130","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/jmcb\/mjt051","article-title":"Wnt signaling in the nervous system and in Alzheimer\u2019s disease.","volume":"6","author":"Inestrosa","year":"2014","journal-title":"J. Mol. Cell Biol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/00005072-199709000-00002","article-title":"APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.","volume":"56","author":"Irizarry","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B132","first-page":"97","article-title":"To G0 or Not to G0: Cell cycle paradox in senescence and brain aging","author":"Ishikawa","year":"2022","journal-title":"Aging mechanisms I : Longevity, metabolism, and brain aging"},{"key":"B133","doi-asserted-by":"publisher","first-page":"729801","DOI":"10.4061\/2011\/729801","article-title":"Attention-deficit\/hyperactivity disorder in childhood is associated with cognitive test profiles in the geriatric population but not with mild cognitive impairment or Alzheimer\u2019s disease.","volume":"2011","author":"Ivanchak","year":"2011","journal-title":"J. Aging Res."},{"key":"B134","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.1371\/journal.pmed.0020355","article-title":"Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease.","volume":"2","author":"Jankowsky","year":"2005","journal-title":"PLoS Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12402-014-0142-1","article-title":"Comorbid mental disorders in children and adolescents with attention-deficit\/hyperactivity disorder in a large nationwide study.","volume":"7","author":"Jensen","year":"2015","journal-title":"Atten. Defic. Hyperact. Disord."},{"key":"B136","doi-asserted-by":"publisher","first-page":"R1198","DOI":"10.1152\/ajpregu.00262.2014","article-title":"Overnutrition, mTOR signaling, and cardiovascular diseases.","volume":"307","author":"Jia","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13041-019-0525-5","article-title":"Restoring Wnt\/beta-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease.","volume":"12","author":"Jia","year":"2019","journal-title":"Mol. Brain"},{"key":"B138","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/0271678X19848510","article-title":"Memory impairment in spontaneously hypertensive rats is associated with hippocampal hypoperfusion and hippocampal vascular dysfunction.","volume":"40","author":"Johnson","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B139","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000364974","article-title":"Modulating mTOR in aging and health.","volume":"40","author":"Johnson","year":"2015","journal-title":"Interdiscip. Top. Gerontol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fnmol.2011.00040","article-title":"GSK-3: Functional insights from cell biology and animal models.","volume":"4","author":"Kaidanovich-Beilin","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.euroneuro.2020.03.011","article-title":"Attention deficit hyperactivity disorder: Last in, first out \u2013 Delayed brain maturation with an accelerated decline?","volume":"34","author":"Kakuszi","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"173378","DOI":"10.1016\/j.pbb.2022.173378","article-title":"Rodent models of attention-deficit hyperactivity disorder: An updated framework for model validation and therapeutic drug discovery.","volume":"216","author":"Kantak","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B143","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer\u2019s disease and related disorders: Mechanisms and therapeutic approaches.","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/pl00000661","article-title":"Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer\u2019s disease and down syndrome.","volume":"57","author":"Kim","year":"2000","journal-title":"Cell Mol. Life Sci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease.","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement. (N. Y.)"},{"key":"B146","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1055\/a-1076-8228","article-title":"Efficacy and safety of psychostimulants for Alzheimer\u2019s disease: A systematic review and meta-analysis.","volume":"53","author":"Kishi","year":"2020","journal-title":"Pharmacopsychiatry"},{"key":"B147","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00702-017-1727-6","article-title":"Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: Risk factors for sporadic Alzheimer\u2019s disease?","volume":"124","author":"Knezovic","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B148","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuropharm.2018.02.027","article-title":"Glucagon-like peptide-1 mediates effects of oral galactose in streptozotocin-induced rat model of sporadic Alzheimer\u2019s disease.","volume":"135","author":"Knezovic","year":"2018","journal-title":"Neuropharmacology"},{"key":"B149","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00702-015-1394-4","article-title":"Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer\u2019s disease.","volume":"122","author":"Knezovic","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B150","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroscience.2014.03.045","article-title":"Linking pathways in the developing and aging brain with neurodegeneration.","volume":"269","author":"Kovacs","year":"2014","journal-title":"Neuroscience"},{"key":"B151","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mad.2019.03.008","article-title":"Crucial players in Alzheimer\u2019s disease and diabetes mellitus: Friends or foes?","volume":"181","author":"Kubis-Kubiak","year":"2019","journal-title":"Mech. Ageing Dev."},{"key":"B152","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.physbeh.2017.03.036","article-title":"Hypothalamic insulin responsiveness is associated with pancreatic insulin secretion in humans.","volume":"176","author":"Kullmann","year":"2017","journal-title":"Physiol. Behav."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","article-title":"Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans.","volume":"96","author":"Kullmann","year":"2016","journal-title":"Physiol. Rev."},{"key":"B154","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jad.2020.05.020","article-title":"Risk of dementia in persons who have previously experienced clinically-significant depression, anxiety, or PTSD: A systematic review and meta-analysis.","volume":"274","author":"Kuring","year":"2020","journal-title":"J. Affect. Disord."},{"key":"B155","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1471-4159.2005.03187.x","article-title":"mTOR\/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer\u2019s disease.","volume":"94","author":"Lafay-Chebassier","year":"2005","journal-title":"J. Neurochem."},{"key":"B156","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11892-019-1174-x","article-title":"Attention deficit\/hyperactivity, the metabolic syndrome, and type 2 diabetes.","volume":"19","author":"Landau","year":"2019","journal-title":"Curr. Diab. Rep."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12402-010-0034-y","article-title":"Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists.","volume":"3","author":"Langen","year":"2011","journal-title":"Atten. Defic. Hyperact. Disord."},{"key":"B158","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5607\/en.2015.24.3.177","article-title":"Roles of mTOR signaling in brain development.","volume":"24","author":"Lee","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13041-016-0207-5","article-title":"Wnt3a upregulates brain-derived insulin by increasing NeuroD1 via Wnt\/beta-catenin signaling in the hypothalamus.","volume":"9","author":"Lee","year":"2016","journal-title":"Mol. Brain"},{"key":"B160","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neulet.2012.07.029","article-title":"Effects of ADHD therapeutic agents, methylphenidate and atomoxetine, on hippocampal neurogenesis in the adolescent mouse dentate gyrus.","volume":"524","author":"Lee","year":"2012","journal-title":"Neurosci. Lett."},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1101\/2022.04.05.22273464","article-title":"Genetic risk for attention-deficit\/hyperactivity disorder predicts cognitive decline and development of Alzheimer\u2019s disease pathophysiology in cognitively unimpaired older adults.","author":"Leffa","year":"2022","journal-title":"medRxiv"},{"key":"B162","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/19336950.2016.1238992","article-title":"T-type calcium channels in synaptic plasticity.","volume":"11","author":"Leresche","year":"2017","journal-title":"Channels (Austin)"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/hbm.22689","article-title":"Toward systems neuroscience in mild cognitive impairment and Alzheimer\u2019s disease: A meta-analysis of 75 fMRI studies.","volume":"36","author":"Li","year":"2015","journal-title":"Hum. Brain Mapp."},{"key":"B164","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.neubiorev.2011.12.001","article-title":"A meta-analysis of voxel-based morphometry studies of white matter volume alterations in Alzheimer\u2019s disease.","volume":"36","author":"Li","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B165","doi-asserted-by":"publisher","first-page":"878036","DOI":"10.3389\/fgene.2022.878036","article-title":"A systematic screening of ADHD-susceptible variants from 25 chinese parents-offspring trios.","volume":"13","author":"Li","year":"2022","journal-title":"Front. Genet."},{"key":"B166","doi-asserted-by":"publisher","first-page":"e19360","DOI":"10.7554\/eLife.19360","article-title":"Regulation of mTORC1 by lysosomal calcium and calmodulin.","volume":"5","author":"Li","year":"2016","journal-title":"Elife"},{"key":"B167","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.yfrne.2014.01.002","article-title":"Sex differences in cognitive impairment and Alzheimer\u2019s disease.","volume":"35","author":"Li","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"109618","DOI":"10.1016\/j.biopha.2019.109618","article-title":"Interaction between hyperphosphorylated tau and pyroptosis in forskolin and streptozotocin induced AD models.","volume":"121","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B169","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-981-13-3540-2_10","article-title":"Mammalian target of rapamycin at the crossroad between Alzheimer\u2019s disease and diabetes.","volume":"1128","author":"Liang","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/biom8040181","article-title":"Dual specificity phosphatase 6 protects neural stem cells from beta-amyloid-induced cytotoxicity through ERK1\/2 Inactivation.","volume":"8","author":"Liao","year":"2018","journal-title":"Biomolecules"},{"key":"B171","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/s0092-8674(02)00685-2","article-title":"Control of beta-catenin phosphorylation\/degradation by a dual-kinase mechanism.","volume":"108","author":"Liu","year":"2002","journal-title":"Cell"},{"key":"B172","doi-asserted-by":"publisher","first-page":"e69199","DOI":"10.7554\/eLife.69199","article-title":"The amyloid precursor protein is a conserved Wnt receptor.","volume":"10","author":"Liu","year":"2021","journal-title":"Elife"},{"key":"B173","doi-asserted-by":"publisher","first-page":"4527283","DOI":"10.1155\/2020\/4527283","article-title":"Shenzhiling oral liquid protects STZ-injured oligodendrocyte through PI3K\/Akt-mTOR pathway.","volume":"2020","author":"Liu","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"B174","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fnmol.2014.00046","article-title":"GSK-3beta, a pivotal kinase in Alzheimer disease.","volume":"7","author":"Llorens-Martin","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"B175","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neurobiolaging.2015.12.023","article-title":"The effect of increased genetic risk for Alzheimer\u2019s disease on hippocampal and amygdala volume.","volume":"40","author":"Lupton","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0197-4580(02)00057-x","article-title":"Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: A meta-analysis.","volume":"24","author":"Lyness","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B177","doi-asserted-by":"publisher","first-page":"e12845","DOI":"10.1371\/journal.pone.0012845","article-title":"Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer\u2019s disease.","volume":"5","author":"Ma","year":"2010","journal-title":"PLoS One"},{"key":"B178","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1042\/BST20170501","article-title":"Mitochondrial abnormalities in Parkinson\u2019s disease and Alzheimer\u2019s disease: Can mitochondria be targeted therapeutically?","volume":"46","author":"Macdonald","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"B179","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1087054714559643","article-title":"Long-term efficacy of methylphenidate immediate-release for the treatment of childhood ADHD.","volume":"21","author":"Maia","year":"2017","journal-title":"J. Atten. Disord."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00109-013-1057-6","article-title":"mTOR and regulation of energy homeostasis in humans.","volume":"91","author":"Mannaa","year":"2013","journal-title":"J. Mol. Med. (Berl)"},{"key":"B181","doi-asserted-by":"publisher","first-page":"e13101","DOI":"10.1111\/acel.13101","article-title":"Parkinson\u2019s disease, aging and adult neurogenesis: Wnt\/beta-catenin signalling as the key to unlock the mystery of endogenous brain repair.","volume":"19","author":"Marchetti","year":"2020","journal-title":"Aging Cell"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","article-title":"ApoE Cascade Hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias.","volume":"110","author":"Martens","year":"2022","journal-title":"Neuron"},{"key":"B183","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0006-8993(90)91747-5","article-title":"Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats.","volume":"532","author":"Mayer","year":"1990","journal-title":"Brain Res."},{"key":"B184","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.neubiorev.2020.12.018","article-title":"Cognitive mechanisms underlying depressive disorders in ADHD: A systematic review.","volume":"121","author":"Mayer","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B185","doi-asserted-by":"publisher","first-page":"13168","DOI":"10.3390\/ijms222313168","article-title":"A review of the current mammalian models of Alzheimer\u2019s disease and challenges that need to be overcome.","volume":"22","author":"McKean","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B186","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41398-021-01578-2","article-title":"Proteomics of autism and Alzheimer\u2019s mouse models reveal common alterations in mTOR signaling pathway.","volume":"11","author":"Mencer","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"B187","doi-asserted-by":"publisher","first-page":"737357","DOI":"10.3389\/fpsyt.2021.737357","article-title":"Mild cognitive impairment or attention-deficit\/hyperactivity disorder in older adults? A cross sectional study.","volume":"12","author":"Mendonca","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cellsig.2012.03.001","article-title":"Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice.","volume":"24","author":"Mines","year":"2012","journal-title":"Cell Signal."},{"key":"B189","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ejphar.2012.10.018","article-title":"Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice.","volume":"698","author":"Mines","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1001\/jamaneurol.2021.3356","article-title":"Effect of methylphenidate on apathy in patients with Alzheimer disease: The ADMET 2 randomized clinical trial.","volume":"78","author":"Mintzer","year":"2021","journal-title":"JAMA Neurol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"110581","DOI":"10.1016\/j.pnpbp.2022.110581","article-title":"Peripheral blood inflammatory markers in patients with attention deficit\/hyperactivity disorder (ADHD): A systematic review and meta-analysis.","volume":"118","author":"Misiak","year":"2022","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.2174\/1871527321666220510144127","article-title":"A systematic review of updated mechanistic insights towards Alzheimer\u2019s disease.","author":"Mittal","year":"2022","journal-title":"CNS Neurol. Disord. Drug Targets."},{"key":"B193","doi-asserted-by":"publisher","first-page":"619626","DOI":"10.3389\/fneur.2021.619626","article-title":"The many faces of astrocytes in Alzheimer\u2019s disease.","volume":"12","author":"Monterey","year":"2021","journal-title":"Front. Neurol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.3233\/JAD-2011-111127","article-title":"Alzheimer\u2019s disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin.","volume":"30","author":"Moreira","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"B195","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41398-020-01033-8","article-title":"ADHD-like behaviors caused by inactivation of a transcription factor controlling the balance of inhibitory and excitatory neuron development in the mouse anterior brainstem.","volume":"10","author":"Morello","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"B196","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bcp.2014.01.008","article-title":"Microglial dysfunction in brain aging and Alzheimer\u2019s disease.","volume":"88","author":"Mosher","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s007020050069","article-title":"Alzheimer\u2019s disease\u2013synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts.","volume":"105","author":"Munch","year":"1998","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B198","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s12031-021-01940-5","article-title":"Molecular insights to the wnt signaling during Alzheimer\u2019s disorder: A potential target for therapeutic interventions.","volume":"72","author":"Nagu","year":"2022","journal-title":"J Mol. Neurosci."},{"key":"B199","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.neuron.2018.03.017","article-title":"Calcium channels, synaptic plasticity, and neuropsychiatric disease.","volume":"98","author":"Nanou","year":"2018","journal-title":"Neuron"},{"key":"B200","doi-asserted-by":"publisher","first-page":"107558","DOI":"10.1016\/j.nlm.2021.107558","article-title":"Role of Wnt signaling in synaptic plasticity and memory.","volume":"187","author":"Narvaes","year":"2022","journal-title":"Neurobiol. Learn. Mem."},{"key":"B201","year":"2021","journal-title":"Treatment of Alzheimer\u2019s disease: How is Alzheimer\u2019s disease treated?."},{"key":"B202","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/1073858416667270","article-title":"How Wnt signaling builds the brain: Bridging development and disease.","volume":"23","author":"Noelanders","year":"2017","journal-title":"Neuroscientist"},{"key":"B203","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00702-018-1949-2","article-title":"Neurogenesis within the hippocampus after chronic methylphenidate exposure.","volume":"126","author":"Oakes","year":"2019","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B204","doi-asserted-by":"publisher","first-page":"713726","DOI":"10.3389\/fnagi.2021.713726","article-title":"Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: A model-AD study.","volume":"13","author":"Oblak","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B205","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1253\/jcj.27.282","article-title":"Development of a strain of spontaneously hypertensive rats.","volume":"27","author":"Okamoto","year":"1963","journal-title":"Jpn. Circ. J."},{"key":"B206","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fphar.2016.00395","article-title":"Judicious toggling of mTOR activity to combat insulin resistance and cancer: Current evidence and perspectives.","volume":"7","author":"Ong","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13195-019-0512-1","article-title":"FDG-PET as an independent biomarker for Alzheimer\u2019s biological diagnosis: A longitudinal study.","volume":"11","author":"Ou","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"B208","doi-asserted-by":"publisher","first-page":"e051121197760","DOI":"10.2174\/1573399818666211105122545","article-title":"Type 2 diabetes mellitus and Alzheimer\u2019s disease: A review of the potential links.","volume":"18","author":"Pakdin","year":"2022","journal-title":"Curr. Diabetes Rev."},{"key":"B209","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fncel.2019.00227","article-title":"Wnt signaling deregulation in the aging and Alzheimer\u2019s brain.","volume":"13","author":"Palomer","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"B210","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1038\/s41380-022-01492-z","article-title":"Epigenetic repression of Wnt receptors in AD: A role for Sirtuin2-induced H4K16ac deacetylation of Frizzled1 and Frizzled7 promoters.","volume":"27","author":"Palomer","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"B211","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1096\/fj.14-253211","article-title":"Activation of the Wnt\/beta-catenin pathway represses the transcription of the beta-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter.","volume":"29","author":"Parr","year":"2015","journal-title":"FASEB J."},{"key":"B212","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.freeradbiomed.2021.04.025","article-title":"mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder.","volume":"169","author":"Perluigi","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/alz.12499","article-title":"Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles.","volume":"18","author":"Perluigi","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B214","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1037\/a0012520","article-title":"Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease.","volume":"122","author":"Pietropaolo","year":"2008","journal-title":"Behav. Neurosci."},{"key":"B215","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/00207459808986466","article-title":"Executive dysfunctions in children with attention deficit hyperactivity disorder.","volume":"96","author":"Pineda","year":"1998","journal-title":"Int. J. Neurosci."},{"key":"B216","doi-asserted-by":"publisher","first-page":"fcac109","DOI":"10.1093\/braincomms\/fcac109","article-title":"Structural progression of Alzheimer\u2019s disease over decades: The MRI staging scheme.","volume":"4","author":"Planche","year":"2022","journal-title":"Brain Commun."},{"key":"B217","doi-asserted-by":"crossref","first-page":"437","DOI":"10.31887\/DCNS.2016.18.4\/cepperson","article-title":"Considering sex and gender in Alzheimer disease and other dementias.","volume":"18","author":"Podcasy","year":"2016","journal-title":"Dialogues Clin. Neurosci."},{"key":"B218","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/0891988720944251","article-title":"A systematic review and comparison of neurocognitive features of late-life attention-deficit\/hyperactivity disorder and dementia with lewy bodies.","volume":"34","author":"Prentice","year":"2021","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"594228","DOI":"10.3389\/fmed.2021.594228","article-title":"Methylphenidate for mild cognitive impairment: An exploratory 3-day, randomized, double-blind, placebo-controlled trial.","volume":"8","author":"Press","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B220","doi-asserted-by":"publisher","first-page":"633495","DOI":"10.3389\/fnagi.2021.633495","article-title":"Impaired learning and memory ability induced by a bilaterally hippocampal injection of streptozotocin in mice: Involved with the adaptive changes of synaptic plasticity.","volume":"13","author":"Qi","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B221","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s13205-021-02900-x","article-title":"Shenzhiling oral solution promotes myelin repair through PI3K\/Akt-mTOR pathway in STZ-induced SAD mice.","volume":"11","author":"Qin","year":"2021","journal-title":"3 Biotech"},{"key":"B222","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41440-021-00704-3","article-title":"Prevalence of mild cognitive impairment in patients with hypertension: A systematic review and meta-analysis.","volume":"44","author":"Qin","year":"2021","journal-title":"Hypertens. Res."},{"key":"B223","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13024-021-00428-5","article-title":"Mammalian\/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration.","volume":"16","author":"Querfurth","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s40120-022-00392-2","article-title":"Molecular characterisation of the mechanism of action of stimulant drugs lisdexamfetamine and methylphenidate on ADHD neurobiology: A review.","volume":"11","author":"Quintero","year":"2022","journal-title":"Neurol. Ther."},{"key":"B225","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ajmg.b.32918","article-title":"ADHD-associated PARK2 copy number variants: A pilot study on gene expression and effects of supplementary deprivation in patient-derived cell lines.","volume":"189","author":"Radtke","year":"2022","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B226","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/jdn.10089","article-title":"Animal models of attention-deficit hyperactivity disorder (ADHD).","volume":"81","author":"Rahi","year":"2021","journal-title":"Int. J. Dev. Neurosci."},{"key":"B227","first-page":"217","article-title":"Sex and age differences in attention-deficit\/hyperactivity disorder symptoms and diagnoses: Implications for DSM-V and ICD-11.","volume":"49","author":"Ramtekkar","year":"2010","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"B228","doi-asserted-by":"publisher","first-page":"788","DOI":"10.2337\/dc20-1549","article-title":"Insulin resistance is associated with enhanced brain glucose uptake during euglycemic hyperinsulinemia: A large-scale PET cohort.","volume":"44","author":"Rebelos","year":"2021","journal-title":"Diabetes Care"},{"key":"B229","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3233\/JAD-132060","article-title":"Inhibitors of mitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction.","volume":"40","author":"Reddy","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B230","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1212\/NXG.0000000000000512","article-title":"Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference?","volume":"6","author":"Reitz","year":"2020","journal-title":"Neurol. Genet."},{"key":"B231","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00702-017-1763-2","article-title":"The diabetic brain and cognition.","volume":"124","author":"Riederer","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B232","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0028-3908(79)90157-6","article-title":"\u201cParadoxical\u201d effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology.","volume":"18","author":"Robbins","year":"1979","journal-title":"Neuropharmacology"},{"key":"B233","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1037\/a0030488","article-title":"Physical exercise and catecholamine reuptake inhibitors affect orienting behavior and social interaction in a rat model of attention-deficit\/hyperactivity disorder.","volume":"126","author":"Robinson","year":"2012","journal-title":"Behav. Neurosci."},{"key":"B234","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1326-7-28","article-title":"Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult.","volume":"7","author":"Rodgers","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"B235","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41467-021-21057-y","article-title":"Asymmetric thinning of the cerebral cortex across the adult lifespan is accelerated in Alzheimer\u2019s disease.","volume":"12","author":"Roe","year":"2021","journal-title":"Nat. Commun."},{"key":"B236","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1471-4159.2009.06566.x","article-title":"Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease.","volume":"112","author":"Rosi","year":"2010","journal-title":"J. Neurochem."},{"key":"B237","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0193-953X(03)00112-6","article-title":"Executive dysfunction in attention-deficit\/hyperactivity disorder: Cognitive and neuroimaging findings.","volume":"27","author":"Roth","year":"2004","journal-title":"Psychiatr. Clin. North Am."},{"key":"B238","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41386-020-0664-5","article-title":"Shared genetic background between children and adults with attention deficit\/hyperactivity disorder.","volume":"45","author":"Rovira","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"B239","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.brainres.2009.11.040","article-title":"Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer\u2019s disease.","volume":"1311","author":"Rustay","year":"2010","journal-title":"Brain Res."},{"key":"B240","doi-asserted-by":"publisher","first-page":"CD012197","DOI":"10.1002\/14651858.CD012197.pub2","article-title":"Pharmacological interventions for apathy in Alzheimer\u2019s disease.","volume":"5","author":"Ruthirakuhan","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"B241","doi-asserted-by":"publisher","first-page":"e33693","DOI":"10.1371\/journal.pone.0033693","article-title":"Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice.","volume":"7","author":"Sadasivan","year":"2012","journal-title":"PLoS One"},{"key":"B242","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/7854_2011_126","article-title":"Rat models of ADHD.","volume":"9","author":"Sagvolden","year":"2012","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"B243","doi-asserted-by":"publisher","first-page":"115697","DOI":"10.1016\/j.taap.2021.115697","article-title":"Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer\u2019s disease in mice via modulating neuroinflammation, PI3K\/Akt, Wnt\/beta-catenin, AMPK\/mTOR signaling pathways.","volume":"429","author":"Salem","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B244","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00702-011-0651-4","article-title":"Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer\u2019s disease: A long-term follow up study.","volume":"118","author":"Salkovic-Petrisic","year":"2011","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B245","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2022.108277","article-title":"Experimental approach to Alzheimer\u2019s disease with emphasis on insulin resistance in the brain","author":"Salkovic-Petrisic","year":"2021","journal-title":"Handbook of neurotoxicity"},{"key":"B246","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000464422","article-title":"Molecular Pathogenesis of Alzheimer\u2019s disease: An update.","volume":"24","author":"Sanabria-Castro","year":"2017","journal-title":"Ann. Neurosci."},{"key":"B247","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/acps.13283","article-title":"Prevalence of attention-deficit\/hyperactivity disorder in people with mood disorders: A systematic review and meta-analysis.","volume":"143","author":"Sandstrom","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"B248","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease.","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"B249","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S2215-0366(17)30167-0","article-title":"ADHD in children and young people: prevalence, care pathways, and service provision.","volume":"5","author":"Sayal","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"B250","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bbr.2009.12.002","article-title":"Early behavioural markers of disease in P301S tau transgenic mice.","volume":"208","author":"Scattoni","year":"2010","journal-title":"Behav. Brain Res."},{"key":"B251","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neubiorev.2021.01.017","article-title":"Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis.","volume":"124","author":"Schiweck","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B252","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijdevneu.2018.12.004","article-title":"Methylphenidate alters Akt-mTOR signaling in rat pheochromocytoma cells.","volume":"73","author":"Schmitz","year":"2019","journal-title":"Int. J. Dev. Neurosci."},{"key":"B253","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.3233\/JAD-132618","article-title":"Interplay between age, cerebral small vessel disease, parenchymal amyloid-beta, and tau pathology: Longitudinal studies in hypertensive stroke-prone rats.","volume":"42","author":"Schreiber","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B254","doi-asserted-by":"publisher","first-page":"23","DOI":"10.12688\/f1000research.12155.1","article-title":"Inhibitory control of the excitatory\/inhibitory balance in psychiatric disorders.","volume":"7","author":"Selten","year":"2018","journal-title":"F1000Research"},{"key":"B255","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4103\/1673-5374.343908","article-title":"The Wnt\/beta-catenin signaling: A multifunctional target for neuroprotective and regenerative strategies in Parkinson\u2019s disease.","volume":"18","author":"Serafino","year":"2023","journal-title":"Neural Regen. Res."},{"key":"B256","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3233\/jad-2007-12108","article-title":"Genetics of Alzheimer\u2019s disease. A rapidly evolving field.","volume":"12","author":"Serretti","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"B257","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0024-3205(00)01005-5","article-title":"Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment.","volume":"68","author":"Sharma","year":"2001","journal-title":"Life Sci."},{"key":"B258","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/gerona\/60.3.293","article-title":"Evidence for down-regulation of phosphoinositide 3-kinase\/Akt\/mammalian target of rapamycin (PI3K\/Akt\/mTOR)-dependent translation regulatory signaling pathways in Ames dwarf mice.","volume":"60","author":"Sharp","year":"2005","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"B259","doi-asserted-by":"publisher","first-page":"19649","DOI":"10.1073\/pnas.0707741104","article-title":"Attention-deficit\/hyperactivity disorder is characterized by a delay in cortical maturation.","volume":"104","author":"Shaw","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B260","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1176\/appi.ajp.2008.08050781","article-title":"Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder.","volume":"166","author":"Shaw","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"B261","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41386-022-01435-w","article-title":"Prefrontal parvalbumin interneurons deficits mediate early emotional dysfunction in Alzheimer\u2019s disease.","volume":"48","author":"Shu","year":"2022","journal-title":"Neuropsychopharmacology."},{"key":"B262","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3233\/JAD-210523","article-title":"Sex differences in behavior and molecular pathology in the 5XFAD model.","volume":"85","author":"Sil","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"B263","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","article-title":"The multiplex model of the genetics of Alzheimer\u2019s disease.","volume":"23","author":"Sims","year":"2020","journal-title":"Nat. Neurosci."},{"key":"B264","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/wps.20765","article-title":"Safety of 80 antidepressants, antipsychotics, anti-attention-deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: A large scale systematic meta-review of 78 adverse effects.","volume":"19","author":"Solmi","year":"2020","journal-title":"World Psychiatry"},{"key":"B265","doi-asserted-by":"publisher","first-page":"04009","DOI":"10.7189\/jogh.11.04009","article-title":"The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis.","volume":"11","author":"Song","year":"2021","journal-title":"J. Glob. Health"},{"key":"B266","doi-asserted-by":"publisher","first-page":"e74660","DOI":"10.1371\/journal.pone.0074660","article-title":"Spatial memory in spontaneously hypertensive rats (SHR).","volume":"8","author":"Sontag","year":"2013","journal-title":"PLoS One"},{"key":"B267","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12402-010-0019-x","article-title":"Animal models of attention deficit\/hyperactivity disorder (ADHD): A critical review.","volume":"2","author":"Sontag","year":"2010","journal-title":"Atten. Defic. Hyperact. Disord."},{"key":"B268","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3233\/JAD-210174","article-title":"The excess costs of dementia: A systematic review and meta-analysis.","volume":"83","author":"Sontheimer","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"B269","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3390\/jcm11102839","article-title":"Transcranial direct current stimulation as an approach to mitigate neurodevelopmental disorders affecting excitation\/inhibition balance: Focus on autism spectrum disorder, schizophrenia, and attention deficit\/hyperactivity disorder.","volume":"11","author":"Sousa","year":"2022","journal-title":"J. Clin. Med."},{"key":"B270","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2010.05.013","article-title":"Characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease: part 1. Circadian changes.","volume":"1348","author":"Sterniczuk","year":"2010","journal-title":"Brain Res."},{"key":"B271","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/brain\/awab294","article-title":"Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer\u2019s disease.","volume":"145","author":"Strom","year":"2022","journal-title":"Brain"},{"key":"B272","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1001\/archneur.61.4.556","article-title":"Executive dysfunction in Alzheimer disease.","volume":"61","author":"Swanberg","year":"2004","journal-title":"Arch. Neurol."},{"key":"B273","doi-asserted-by":"publisher","first-page":"e21050","DOI":"10.1371\/journal.pone.0021050","article-title":"P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating.","volume":"6","author":"Takeuchi","year":"2011","journal-title":"PLoS One"},{"key":"B274","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B275","doi-asserted-by":"publisher","first-page":"e051117","DOI":"10.1002\/alz.051117","article-title":"Brain-region-specific, glycosylation-related transcriptomic alterations in Alzheimer\u2019s disease.","volume":"17","author":"Tang","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B276","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.4103\/1673-5374.238606","article-title":"Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer\u2019s disease.","volume":"13","author":"Tapia-Rojas","year":"2018","journal-title":"Neural Regen. Res."},{"key":"B277","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2174\/1871527315666160527155014","article-title":"Neuroinflammatory markers in spontaneously hypertensive rat brain: An immunohistochemical study.","volume":"15","author":"Tayebati","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B278","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.15277","article-title":"Activation of Wnt\/beta-catenin signaling restores insulin sensitivity in insulin resistant neurons through transcriptional regulation of IRS-1.","volume":"157","author":"Tian","year":"2021","journal-title":"J. Neurochem."},{"key":"B279","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41419-022-04784-y","article-title":"Simvastatin rescues memory and granule cell maturation through the Wnt\/beta-catenin signaling pathway in a mouse model of Alzheimer\u2019s disease.","volume":"13","author":"Tong","year":"2022","journal-title":"Cell Death Dis."},{"key":"B280","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.brainres.2019.05.031","article-title":"Sex differences in Alzheimer\u2019s disease: Understanding the molecular impact.","volume":"1719","author":"Toro","year":"2019","journal-title":"Brain Res."},{"key":"B281","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/jnc.13037","article-title":"Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): Analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.","volume":"133","author":"Tramutola","year":"2015","journal-title":"J. Neurochem."},{"key":"B282","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/1087054717714057","article-title":"Risk of dementia in adults with ADHD: A nationwide, population-based cohort study in taiwan.","volume":"23","author":"Tzeng","year":"2019","journal-title":"J. Atten. Disord."},{"key":"B283","year":"2021","journal-title":"Aducanumab (marketed as Aduhelm) information [Online]."},{"key":"B284","year":"2023","journal-title":"FDA grants accelerated approval for Alzheimer\u2019s disease treatment [Online]."},{"key":"B285","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/iub.2324","article-title":"Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer\u2019s disease.","volume":"72","author":"Uddin","year":"2020","journal-title":"IUBMB Life"},{"key":"B286","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1046\/j.1460-9568.2003.02444.x","article-title":"Age-dependent cognitive decline in the APP23 model precedes amyloid deposition.","volume":"17","author":"Van Dam","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"B287","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13195-022-01089-2","article-title":"Altered basal forebrain function during whole-brain network activity at pre- and early-plaque stages of Alzheimer\u2019s disease in TgF344-AD rats.","volume":"14","author":"van den Berg","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"B288","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pbb.2006.02.018","article-title":"Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.","volume":"83","author":"van den Bergh","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B289","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1523\/JNEUROSCI.2144-20.2021","article-title":"mTOR attenuation with rapamycin reverses neurovascular uncoupling and memory deficits in mice modeling Alzheimer\u2019s disease.","volume":"41","author":"Van Skike","year":"2021","journal-title":"J. Neurosci."},{"key":"B290","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1126\/science.1137931","article-title":"Attention-like processes in Drosophila require short-term memory genes.","volume":"315","author":"van Swinderen","year":"2007","journal-title":"Science"},{"key":"B291","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1523\/JNEUROSCI.4516-09.2010","article-title":"Attention-like deficit and hyperactivity in a Drosophila memory mutant.","volume":"30","author":"van Swinderen","year":"2010","journal-title":"J. Neurosci."},{"key":"B292","doi-asserted-by":"publisher","first-page":"e5989","DOI":"10.1371\/journal.pone.0005989","article-title":"Shared visual attention and memory systems in the Drosophila brain.","volume":"4","author":"van Swinderen","year":"2009","journal-title":"PLoS One"},{"key":"B293","doi-asserted-by":"publisher","first-page":"101337","DOI":"10.1016\/j.eclinm.2022.101337","article-title":"Global and regional spending on dementia care from 2000-2019 and expected future health spending scenarios from 2020-2050: An economic modelling exercise.","volume":"45","author":"Velandia","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B294","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.toxlet.2021.12.009","article-title":"iPSC-derived cortical neurons to study sporadic Alzheimer disease: A transcriptome comparison with post-mortem brain samples.","volume":"356","author":"Verheijen","year":"2022","journal-title":"Toxicol. Lett."},{"key":"B295","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jaac.2021.08.023","article-title":"Meta-analysis: Dose-dependent effects of methylphenidate on neurocognitive functioning in children with attention-deficit\/hyperactivity disorder.","volume":"61","author":"Vertessen","year":"2022","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"B296","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1038\/s41598-021-82710-6","article-title":"Repurposing a digital kitchen scale for neuroscience research: A complete hardware and software cookbook for PASTA.","volume":"11","author":"Virag","year":"2021","journal-title":"Sci. Rep."},{"key":"B297","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2147\/NSS.S163074","article-title":"Sleep disorders in patients with ADHD: Impact and management challenges.","volume":"10","author":"Wajszilber","year":"2018","journal-title":"Nat. Sci. Sleep"},{"key":"B298","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3174\/ajnr.A6560","article-title":"Methylphenidate effects on cortical thickness in children and adults with attention-deficit\/hyperactivity disorder: A randomized clinical trial.","volume":"41","author":"Walhovd","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"B299","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bbr.2011.03.049","article-title":"Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer\u2019s disease.","volume":"222","author":"Walker","year":"2011","journal-title":"Behav. Brain Res."},{"key":"B300","doi-asserted-by":"publisher","first-page":"301575","DOI":"10.1155\/2014\/301575","article-title":"The role of Wnt signaling in the development of Alzheimer\u2019s disease: A potential therapeutic target?","volume":"2014","author":"Wan","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B301","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10654-021-00756-2","article-title":"Maternal hypertensive disorders and neurodevelopmental disorders in offspring: A population-based cohort in two Nordic countries.","volume":"36","author":"Wang","year":"2021","journal-title":"Eur. J. Epidemiol."},{"key":"B302","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3233\/JAD-170786","article-title":"Medical comorbidity in Alzheimer\u2019s disease: A nested case-control study.","volume":"63","author":"Wang","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B303","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease.","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B304","doi-asserted-by":"publisher","first-page":"10347","DOI":"10.1523\/JNEUROSCI.1470-11.2011","article-title":"Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood.","volume":"31","author":"Warren","year":"2011","journal-title":"J. Neurosci."},{"key":"B305","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","article-title":"A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease.","volume":"53","author":"Wightman","year":"2021","journal-title":"Nat. Genet."},{"key":"B306","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3389\/fimmu.2017.00508","article-title":"Mitochondria-derived damage-associated molecular patterns in neurodegeneration.","volume":"8","author":"Wilkins","year":"2017","journal-title":"Front. Immunol."},{"key":"B307","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s13311-012-0135-8","article-title":"The prevalence of DSM-IV attention-deficit\/hyperactivity disorder: A meta-analytic review.","volume":"9","author":"Willcutt","year":"2012","journal-title":"Neurotherapeutics"},{"key":"B308","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.biopsych.2005.02.006","article-title":"Validity of the executive function theory of attention-deficit\/hyperactivity disorder: A meta-analytic review.","volume":"57","author":"Willcutt","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"B309","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/0278-5846(86)90051-5","article-title":"Validation criteria for animal models of human mental disorders: Learned helplessness as a paradigm case.","volume":"10","author":"Willner","year":"1986","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B310","doi-asserted-by":"publisher","first-page":"952096","DOI":"10.3389\/fnins.2022.952096","article-title":"EAAT2 as a therapeutic research target in Alzheimer\u2019s disease: A systematic review.","volume":"16","author":"Wood","year":"2022","journal-title":"Front. Neurosci."},{"key":"B311","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.tibs.2009.10.002","article-title":"GSK3: A multifaceted kinase in Wnt signaling.","volume":"35","author":"Wu","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"B312","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neulet.2018.04.008","article-title":"Abnormal circadian locomotor rhythms and Per gene expression in six-month-old triple transgenic mice model of Alzheimer\u2019s disease.","volume":"676","author":"Wu","year":"2018","journal-title":"Neurosci. Lett."},{"key":"B313","doi-asserted-by":"publisher","first-page":"10698","DOI":"10.1111\/jcmm.17006","article-title":"LiCl attenuates impaired learning and memory of APP\/PS1 mice, which in mechanism involves alpha7 nAChRs and Wnt\/beta-catenin pathway.","volume":"25","author":"Xiang","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"B314","doi-asserted-by":"publisher","first-page":"100944","DOI":"10.1016\/j.arr.2019.100944","article-title":"Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies.","volume":"55","author":"Xue","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"B315","doi-asserted-by":"publisher","first-page":"6625","DOI":"10.1038\/s41598-022-10554-9","article-title":"Transcriptome analysis of fasudil treatment in the APPswe\/PSEN1dE9 transgenic (APP\/PS1) mice model of Alzheimer\u2019s disease.","volume":"12","author":"Yan","year":"2022","journal-title":"Sci. Rep."},{"key":"B316","doi-asserted-by":"publisher","first-page":"964463","DOI":"10.3389\/fnagi.2022.964463","article-title":"Prediction value of the genetic risk of type 2 diabetes on the amnestic mild cognitive impairment conversion to Alzheimer\u2019s disease.","volume":"14","author":"Yang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"B317","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-014-1328-5","article-title":"Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer\u2019s disease and tauopathies.","volume":"128","author":"Yarchoan","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B318","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41398-020-00999-9","article-title":"The stress-Wnt-signaling axis: A hypothesis for attention-deficit hyperactivity disorder and therapy approaches.","volume":"10","author":"Yde Ohki","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"B319","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1056\/NEJM199011153232001","article-title":"Cerebral glucose metabolism in adults with hyperactivity of childhood onset.","volume":"323","author":"Zametkin","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"B320","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/alz.12462","article-title":"Attention-deficit\/hyperactivity disorder and Alzheimer\u2019s disease and any dementia: A multi-generation cohort study in Sweden.","volume":"18","author":"Zhang","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B321","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-9562.1000329","article-title":"Alzheimer\u2019s model develops early ADHD syndrome.","volume":"6","author":"Zhang","year":"2015","journal-title":"J. Neurol. Neurophysiol."},{"key":"B322","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","article-title":"The prevalence of neuropsychiatric symptoms in Alzheimer\u2019s disease: Systematic review and meta-analysis.","volume":"190","author":"Zhao","year":"2016","journal-title":"J. Affect. Disord."},{"key":"B323","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s12576-017-0561-9","article-title":"Xanthoceraside modulates neurogenesis to ameliorate cognitive impairment in APP\/PS1 transgenic mice.","volume":"68","author":"Zhu","year":"2018","journal-title":"J. Physiol. Sci."},{"key":"B324","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/mrdd.20163","article-title":"Alzheimer\u2019s disease in Down syndrome: neurobiology and risk.","volume":"13","author":"Zigman","year":"2007","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"B325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges.","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"key":"B326","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.numecd.2021.03.020","article-title":"Metabolic syndrome and the risk of late onset Alzheimer\u2019s disease: An updated review and meta-analysis.","volume":"31","author":"Zuin","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1104985\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T06:26:39Z","timestamp":1676528799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1104985\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":326,"alternative-id":["10.3389\/fnins.2023.1104985"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1104985","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"article-number":"1104985"}}